Belvedere Trading LLC Aldeyra Therapeutics, Inc. Transaction History

Belvedere Trading LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$7.11 - $11.89 $135,594 - $226,754	-19,071 Reduced 76.2%	5,956 $49,000
Q1 2023 May 15, 2023	BUY	$5.77 - $9.93 $144,405 - $248,518	25,027 New	25,027 $248,000
Q1 2022 Apr 20, 2022	SELL	$3.25 - $5.17 $86,966 - $138,344	-26,759 Reduced 52.25%	24,457 $98,000
Q4 2021 Jan 25, 2022	BUY	$3.5 - $9.63 $129,412 - $356,069	36,975 Added 259.64%	51,216 $166,000
Q3 2021 Oct 19, 2021	BUY	$7.94 - $11.31 $113,073 - $161,065	14,241 New	14,241 $119,000
Q2 2021 Jul 23, 2021	SELL	$10.44 - $14.85 $213,404 - $303,548	-20,441 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$6.53 - $14.42 $133,479 - $294,759	20,441 New	20,441 $243,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $283M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.